Dr. Goldman concluded on the approval of chickenpox vaccines:
... a combination of financial conflicts of interests, lack of proper controls, and poor methodology in varicella studies commissioned by the CDC often yielded improper or confounded results and conclusions— producing research based on pseudoscience that should more appropriately be relegated to a faith-based belief system rather than the realm of science.
A couple of days ago, it was reported that 18 people have filed a lawsuit against Merck, because allegedly its Zostavax shingles vaccine causes shingles: “Merck knew or should have known that its product caused viral infection and was therefore not safe”.
At least 80 deaths associated with the Zostavax vaccine were reported to the Vaccine Adverse Event Reporting System (VAERS), along with over 100,000 reports of other adverse side effects. Only a portion of all adverse effects are reported in VAERS.
According to Dr. Robert Scott Bell the vaccine fails because: “it’s not facilitating natural antibody production”.
Bell thinks: “on some level, it’s by design” and vaccines are one of many medical weapons of the “disease creation machinery”: https://www.naturalnews.com/2018-08-28- ... njury.html#
Once again Naturalnews.com leaves out the best information…
Natural chickenpox (varicella) infection in most children (99.9% of healthy children) is a mild disease and results in long-lasting immunity.
In 1995, the Centers for Disease Control and Prevention (CDC) approved Merck's chickenpox vaccine Varivax. The varicella vaccine’s protection is only temporary, leaving vaccinated individuals vulnerable to infection at an older age when chickenpox is more serious.
In 2000, the CDC reported that between March 1995 and July 1998, the Vaccine Adverse Events Reporting System (VAERS) had received 67.5 adverse event reports per 100,000 doses (1 in 1,481), including bacterial infections (cellulites), transverse myelitis, Guillain Barre syndrome and herpes zoster (shingles).
Gary S. Goldman, served from 1995 until his resignation in 2002 as a researcher for the Varicella Active Surveillance Project in a cooperative project with the CDC. Goldman resigned after he was prevented from publishing his findings about the expected negative impacts of massive vaccination of children with the varicella zoster vaccines.
Goldman predicted that widespread chickenpox vaccination would lead to a loss of natural immunity and a spike create a shingles epidemic among adults and warned of a "50-year shingles epidemic":
Goldman thought that a shingles vaccine “would likely fail because adult vaccination programs have rarely proved successful”.the universal varicella vaccination program in the United States...will leave our population vulnerable to shingles epidemics...there appears to be no way to avoid a mass epidemic of shingles lasting as long as several generations among adults.
Chickenpox and herpes zoster (HZ, or shingles) are caused by closely related viruses. Shingles used to relatively rare. Shingles is painful, and can be very serious.
So by vaccination, in exchange for avoiding the relatively mild “one week nuisance” of chickenpox as a kid, big pharma has created a new, more dangerous atypical adult form of the illness, and an epidemic of shingles.
The Food and Drug Administration (FDA) approved Merck's shingles vaccine, Zostavax, to poison people aged 60 and older in 2006 to fix the problem caused by Merck's chickenpox vaccine Varivax, but reportedly "duration of protection after vaccination with Zostavax is unknown".
Big pharma sells their products by what I sometimes refer to as statistrics. The “new” shingles vaccine Zostavax was once heralded as decreasing the rate of shingles with 50%. To gullible fools this sounds impressive.
This really means that the occurrence of shingles went down from 3.3% to 1.7% in the trial. You could just as well label this (50%) as a decrease of a mere 1.6% or conclude that 63 vaccinations are required to prevent a single infection. This sounds a lot less impressive, especially when you consider that every vaccine has adverse effects or that the remaining infections could be worse than the disease without vaccine!
Without specific information on the trial this doesn’t even “prove” that 63 vaccinations on average would prevent 1 shingles infection. The reported decrease from 3.3% to 1.7% in the trial was for age 60; the claimed efficacy falls to only 18% for age 80 and above (for example from 3.3% to 2.7%).
Vaccine manufacturers even admit that the “protection” of the vaccine wanes in time (so we need additional “booster” shots): http://www.mountainrunnerdoc.com/the-sh ... demic.html
(archived here: http://archive.is/9NhQS)
I’ve found a 2013 scientific looking report with Goldman as an author.
In 2000, the vaccination campaign had decreased the varicella incidence dramatically to 28% of the pre-vaccine rate - from 2834 in 1995 to 836 in 2000. By 2002, the varicella vaccination efficacy fell below 80%.
From 2000 to 2001, HZ (shingles) incidence significantly increased among adults aged 20–69 years. Children that were previously infected with varicella demonstrated (high) HZ rates similar to adults. The CDC still claimed that no increase in HZ had occurred in any US surveillance site.
From 2000 to 2001, Goldman noted that the number of HZ case reports had maintained or increased in every adult age category except adults aged 70 years and older. The increase in HZ cases for ages 20–69 from 158 in 2000 to 203 in 2001 (a 28.5% increase) is statistically significant.
The light grey bars are hard to see…
From January 2000 - April 2002 (2 years and 4 months) the recurrent HZ incidence rate (a second infection after an earlier infection) was 2440/100,000 p-y. This is 3.3 times as high as the 744/100,000 p-y reported before varicella vaccination was approved.
Yih et al. reported and 22.5% annual increase from 1999 to 2003 in Massachusetts.
The AV-VASP reported an increase of 28% from 2006 to 2007 among adults aged 50 years and older and even a 38% increase in HZ incidence among adults aged 50–59 years.
From 2000 to 2006, the HZ incidence in age group 10–19 approximately doubled.
After Goldman resigned because he wasn’t allowed to publish his findings on the relationship between the chickenpox vaccination and the shingles “epidemic”, Dr. Laurene Mascola of the ACDC Unit of LADHS demanded that he wouldn’t publish his report. After Goldman hired attorneys the county dropped its opposition to publication in a medical journal.
Goldman’s main conclusions are:
• The high recurrent HZ incidence rate of 2440/100,000 p-y relative to the 744/100,000 p-y reported by Donahue et al. .
• The high HZ incidence rate among children under 10 years of age with a prior history of natural varicella of 307/100,000 p-y during 2000–2001  and 446/100,000 p-y during 2000–2003 —higher than any other historical rates.
• The 18% overall increase in adult HZ from 2000 to 2001; case counts maintained or increased in every age category except elderly adults 70+ years (Fig. 1); the 28.5% increase in HZ reports among adults 20–59 years was statistically significant (p < 0.042).
• The 56% increase in HZ case reports among adults 20 years of age and older from 236 in 2000 to 368 in 2002 .
• Baseline prevaccine cumulative 1987–1995 true HZ incidence rate of 145/100,000 p-y among children under 10 years of age .
In 2006, 20% of children that had been vaccinated were infected with varicella and so the CDC recommended a booster shot for children (for every health problem, the "solution" is another shot...). The CDC ignored the assumptions that had justified the initial approval of the vaccine of life-long “immunity”.
In 2007, the HZ (shingles) vaccine Merck's Zostavax was approved for adults aged 60 and older.
In 2011, the FDA approved Zostavax for adults aged 50 and older.
Zostavax was approved based on a study (was an inert placebo used?) that showed an HZ incidence rate of 5.42 cases/1000 p-y in the vaccinated group compared to 11.12 cases/1000 p-y for the placebo group.
That would probably be called a 50% efficacy…
Because the vaccine “protection” wanes efficacy is lower.
Eliminating varicella (chickenpox) in the US (280 million) would prevent approximately 186 million cases of varicella and 5,000 deaths over 50 years.
Goldman’s model predicts that varicella vaccination would generate an extra 21 million cases of herpes zoster resulting in 5,000 deaths.
Patel et al. report that the net hospitalization costs for complications of HZ have increased by more than $700 million per year by 2004 for adults 60 years and older.
HZ morbidity costs exceed the cost savings from the reported varicella-disease reductions.
G.S. Goldman and P.G. King – Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, …” (2013): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759842/
Based on Goldman’s report, I conclude that possibly the increase in shingles cases was (is) caused by another factor than the chickenpox vaccine...
I’m also not sure about the explanation on how chickenpox vaccination causes an increase in shingles, in people that weren’t vaccinated in the first place.